Delivery Order SPE2DB22D3501-SPE2DB24FWF19

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $35,953.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product, and has a completion date of February 20, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $24,909.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product classified under the National Stock Number 4566858370. The contract is a Firm Fixed Price Delivery Order with a completion date of January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA9S8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $25,141.39 firm fixed-price delivery order is for INFUVITE PEDIATRIC VIAL 5ML medical supplies, with a completion date of March 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,927.07 firm fixed-price delivery order is for INFUVITE PEDIATRIC VIAL 5ML, a medical product, with a period of performance through December 10, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,072.44, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,916.03 firm fixed-price delivery order is for INFUVITE PEDIATRIC VIAL 5ML medical supplies, with a completion date of November 28, 2023. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.45 Firm Fixed Price delivery order is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a medical product. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $13,671.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a medical product, with a completion date of June 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, valued at $999,999,999 and...
This federal contract award, valued at $15,191.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT BULK VIAL 100ML, a pharmaceutical product, with a performance period extending through October 31, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,870.36, is for the delivery of Infuvite Pediatric Vial 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order type, with a completion date of January 22, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a larger Indefinite Delivery...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWF19
    Delivery Order

This federal contract award, valued at $12,543.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565100106 - INFUVITE PEDIATRIC VIAL 5ML, with a completion date of July 10, 2024. This award is under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows DLA to efficiently procure a wide range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. This specific contract award does not have a set-aside designation.

Generated 10/8/24, 9:22 AM